Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation.
about
Delayed graft function in the kidney transplantSelection of induction therapy in kidney transplantationPolyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.Rabbit antithymocyte globulin induction therapy in adult renal transplantation.Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificityAntithymocyte globulin treatment at the time of transplantation impairs donor hematopoietic stem cell engraftment.Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study.Evaluation of alloreactivity in kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker.B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitroPost-transplant de novo malignancies in renal transplant recipients: the past and present.Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study.A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results.Induction therapy in renal transplant recipients: how convincing is the current evidence?The role of Thymoglobulin induction in kidney transplantation: an update.Disruptions in the supply of medications used in transplantation: implications and management strategies for the transplant clinician.Pharmacotherapy of lung transplantation: an overview.Use of polyclonal/monoclonal antibody therapies in transplantation.The appropriate dose of thymoglobulin induction therapy in kidney transplantation.Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.Prolonged lymphopenia following anti-thymocyte globulin induction is associated with decreased long-term graft survival in liver transplant recipientsAntibody induction therapy in adult kidney transplantation: A controversy continues.Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation.Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients.Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation.Immunological induction with thymoglobulin: reduction in the number of doses in renal transplant from deceased donor.Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network.
P2860
Q26824506-837C8F17-450E-48F3-A5C6-F7D79D4D420BQ26864234-E45798B6-5B79-4D1F-A417-3F5726C095F7Q30239091-B8132FDF-4F44-4236-A58E-6FCF1A9DA936Q30987986-40E08374-AA1E-4585-8E8A-F33C3EA7AD96Q33373390-99D7AC95-49A9-4ED2-BF28-BCD6A65C15F1Q33408239-753FCB36-B5EF-4A4C-A54F-2B0FC35BE3C1Q33415472-68372F81-ACD3-4E1F-8118-1CB72272B50FQ33652103-0670D87B-99E6-4398-B40C-5F1B480E9D9CQ34027642-A47CB5EB-A845-43EF-8C8B-FC12B4D7D6DEQ35580676-5F07CE31-EBE1-449D-B6B8-0F33758542B6Q36429791-1CF12ADB-B66B-40DE-8F29-ECF536083611Q36508920-2A20EFA8-11AC-463B-9C30-7C65C216B38CQ36530274-A6809AC6-63DE-439E-A319-E5CD287E04F4Q37169131-5398F2F2-FFBC-49C0-A287-6BDE4CE94061Q37225674-2FDD7418-61F4-4AA0-BD14-096970A17B38Q37996078-B348F261-40AD-4C5E-94DC-0F9A059CA6F2Q38051718-EB8BB7F5-20B6-4CB7-8A41-F5D8116D24CAQ38057787-A373DA0C-501B-4EA7-BE18-B09646EDAB30Q38064388-54FD9AC9-B6FB-4939-8D5A-71D37B39C683Q38769922-0C4F93AD-25C0-4827-9E76-A0122419571FQ40265150-CBA38F28-8EF5-45E9-9657-FA1F2A656AF1Q41161938-DD7D2604-503A-4EC7-A0AC-52D777253601Q42153892-A594762C-FBDD-4832-83B3-8E6A56858F2FQ42969608-B58D9372-DB09-4F7B-8E8C-6E7D69701C43Q45121876-CEC2D207-9700-4CF0-B3BA-6807C4646BEFQ46987447-257330DF-091B-4E5D-8554-FB89C1D68BEEQ49724077-DAC71FA0-7544-4E47-8A50-9F2F86BD520DQ53265118-5802E754-BA6D-40BF-82D9-F657A0AA8A2EQ55266341-C6E89B22-1307-4302-805E-B86621151871
P2860
Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Five-year follow up of thymogl ...... n adult renal transplantation.
@ast
Five-year follow up of thymogl ...... n adult renal transplantation.
@en
type
label
Five-year follow up of thymogl ...... n adult renal transplantation.
@ast
Five-year follow up of thymogl ...... n adult renal transplantation.
@en
prefLabel
Five-year follow up of thymogl ...... n adult renal transplantation.
@ast
Five-year follow up of thymogl ...... n adult renal transplantation.
@en
P2093
P1433
P1476
Five-year follow up of thymogl ...... n adult renal transplantation.
@en
P2093
Brent Miller
Connie Ceriotti
Daniel C Brennan
Decha Enkvetchakul
Jeffrey A Lowell
Karen L Hardinger
Mark A Schnitzler
Matthew J Koch
Surendra Shenoy
P304
P356
10.1097/01.TP.0000132329.67611.3F
P577
2004-07-01T00:00:00Z